Research Training in Blood Diseases and Resources06/01/2014 - 05/31/2021 (Multi-PI)
PI:
Martin H. Steinberg, MDNIH/National Heart, Lung, and Blood Institute5T32HL007501-36
Mechanisms of cis-acting HbF regulation in sickle cell anemia04/01/2017 - 03/31/2021 (Multi-PI)
PI:
Martin H. Steinberg, MDBoston Medical Center Corporation NIH NHLBI5R01HL133350-04
Severity Index for Sickle Cell anemia in the Eastern Province of Saudi Arabia01/01/2013 - 12/31/2018 (PI)
King Faisal University
A prototype diagnostic for cellular fetal hemoglobin in sickle cell disease08/01/2016 - 01/31/2018 (Multi-PI)
PI:
Martin H. Steinberg, MDMyoSyntax Corporation NIH NHLBI1R43HL134529-01
Globin Gene Expression in Sickle Cell Genotype-Specific iPS cells07/05/2011 - 06/30/2017 (Multi-PI)
PI:
Martin H. Steinberg, MDNIH/National Heart, Lung, and Blood Institute5U01HL107443-05
Genetic Basis of Fetal Hemoglobin in Saudi Sickle Cell Anemia01/02/2012 - 12/31/2016 (PI)
University of Dammam Saudi Arabia
Globin Gene Expression in Sickle Cell Genotype-Specific iPS cells07/05/2011 - 06/30/2016 (PI)
NIH/National Heart, Lung, and Blood Institute1U01HL107443-01
A prototype diagnostic for cellular fetal hemoglobin in sickle cell disease08/15/2014 - 01/30/2016 (Subcontract PI)
MyoSyntax Corporation NIH NHLBI1R43HL124679-01
Gene Polymorphism in Chronic Sickle Cell Lung Disease01/01/2005 - 12/31/2009 (Dept Sponsor)
NIH/National Heart, Lung, and Blood Institute5 K23 HL79003 05
Genetic Modulation of Sickle Cell Anemia05/01/2006 - 04/30/2009 (PI)
NIH/Fogarty International Center5 R03 TW07189 03
Showing 10 of 13 results.
Show All Results
Determinants of HbF Response to Hydroxyurea07/01/2002 - 04/30/2007 (PI)
NIH/National Heart, Lung, and Blood Institute5 R01 HL70735 04
A Phase II, Multicenter, Twelve-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Range-Finding Study of the Efficacy and Safety of ICA-17043 with or without Hydorxyurea Therapy in Patients with Sickle Cell Anemia01/17/2002 - 01/16/2003 (Co-PI)
PI:
Lillian E.C. McMahon, MDIcaGen, Inc.
Controlled Study to Determine the Effects of Procrit kEpoetin Alfa in Patients with Sickle Cell Anemia Who are Receiving Hydroxyurea01/17/2002 - 01/16/2003 (Co-PI)
PI:
Lillian E.C. McMahon, MDOrtho Biotech Inc
BTRP Admin Core04/01/2008 - 03/31/2012 (PI)
NIH-NHLBI5U54 HL070819-08
BTRP Clinical Trials04/01/2008 - 03/31/2012 (PI)
NIH-NHLBI5U54 HL070819-07
BTRP Research Scholar04/01/2008 - 03/31/2012 (PI)
NIH-NHLBI5U54 HL070819-07
BTRP Subcontracts04/01/2008 - 03/31/2012 (PI)
NIH-NHLBI5U54 HL070819-08
BTRP Training Supplement04/01/2008 - 03/31/2012 (PI)
NIH-NHLBI2U54 HL070819-06
CSSC Admin Core04/01/2008 - 03/31/2012 (PI)
NIH-NHLBI2U54 HL070819-06
CSSC Butyrate04/01/2008 - 03/31/2012 (PI)
NIH-NHLBI2U54 HL070819-06
CSSC Clinical Core04/01/2008 - 03/31/2012 (PI)
NIH-NHLBI2U54 HL070819-06
CSSC Geno-Pheno Core Lab04/01/2008 - 03/31/2012 (PI)
NIH-NHLBI2U54 HL070819-06
CSSC Patient Service Core04/01/2008 - 03/31/2012 (PI)
NIH-NHLBI2U54 HL070819-06
Showing 10 of 18 results.
Show All Results
Training Supplement Boston Comprehensive Sickle Cell Center04/01/2005 - 03/31/2008 (PI)
NIH-NHLBI5U54 HL070819 - 05S1
Sickel Cell - Clinical Core04/01/2003 - 03/31/2008 (PI)
NIH-NHLBI5 U54 HL070819-05
Sickle Cell - Administrative Core04/01/2003 - 03/31/2008 (PI)
NIH-NHLBI5 U54 HL070819-05
Sickle Cell - Patient Services Core04/01/2003 - 03/31/2008 (PI)
NIH-NHLBI5 U54 HL070819-05
Sickle Cell - Subcontracts + Intercenter04/01/2003 - 03/31/2008 (PI)
NIH-NHLBI5 U54 HL070819-05 (A)
Sickle Cell - Summer Science Program04/01/2003 - 03/31/2008 (PI)
NIH-NHLBI5 U54 HL070819-05
Statistics and Data Management-CSCC04/01/2003 - 09/30/2005 (PI)
RhoFed NIH-NHLBIU54HL070587
Comprehensive Sickle Cell Ctr01/01/1992 - 03/31/2004 (PI)
NIH-NHLBI5 P60 HL15157-31 (F)